Clinical Study
Value of C-Reactive Protein as a Risk Factor for Acute Coronary Syndrome: A Comparison with Apolipoprotein Concentrations and Lipid Profile
Table 4
The risk of the acute coronary syndrome for primary variables.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Model 0 unadjusted: = 131.7; df = 7; P < 0.001; log-likelihood = 275.5; Cox and Snell = 0.34; Nagelkerke = 0.47. Model 1 adjusted for age: = 241.9; df = 8; P < 0.001; log-likelihood = 165.3; Cox and Snell = 0.53; Nagelkerke = 0.74. Model 2 adjusted for age and sex: = 251.0; df = 9; P < 0.001; log-likelihood = 156.2; Cox and Snell = 0.54; Nagelkerke = 0.75. Model 3 adjusted for age, sex, and smoking status: = 219.7; df = 10; P < 0.001; log-likelihood = 64.6; Cox and Snell = 0.62; Nagelkerke = 0.86. apoA-I: apolipoprotein A-I; apoB: apolipoprotein B; CI: confidence interval; HDL-C: high-density lipoprotein cholesterol; hsCRP: high-sensitivity C-reactive protein; LDL-C: low-density lipoprotein cholesterol; ns: not significant; OR: odds ratio; TC: total cholesterol; TG: triglycerides. |